Covered recipient · General Payments record
KRISTEN TOBIN VEALEY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$447.13
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $344.31 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $139.04 | 9 |
| Acerta Pharma LLC | $64.26 | 3 |
| PFIZER INC. | $60.81 | 2 |
| Novo Nordisk AS | $45.46 | 3 |
| SCPHARMACEUTICALS INC. | $34.74 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $23.36 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105864740 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.29 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104422639 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.61 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104583226 | CMS |
| Lilly USA, LLC | $6.30 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135126630 | CMS |
| Lilly USA, LLC | $16.29 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135110638 | CMS |
| Lilly USA, LLC | $12.25 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135116971 | CMS |
| Lilly USA, LLC | $19.77 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135080420 | CMS |
| Lilly USA, LLC | $18.50 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135116973 | CMS |
| Lilly USA, LLC | $12.70 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135116969 | CMS |
| Lilly USA, LLC | $23.32 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135080422 | CMS |
| Lilly USA, LLC | $4.34 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135080424 | CMS |
| Lilly USA, LLC | $25.57 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135110636 | CMS |
| Novo Nordisk Inc | $13.58 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097136005 | CMS |
| Novo Nordisk Inc | $16.58 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096872489 | CMS |
| Novo Nordisk Inc | $15.30 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097804485 | CMS |
| PFIZER INC. | $25.24 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130914022 | CMS |
| PFIZER INC. | $35.57 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130920611 | CMS |
| SCPHARMACEUTICALS INC. | $21.67 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132253964 | CMS |
| SCPHARMACEUTICALS INC. | $13.07 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132292486 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.